Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Entero Therapeutics Inc ENTO

Entero Therapeutics, Inc., formerly First Wave BioPharma, Inc., is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. Its programs address unmet needs in GI health and include latiglutenase, a Phase III-ready, oral biotherapeutic designed to aid gluten digestion and potentially reduce symptoms of... see more

Bullboard (NDAQ:ENTO)

View:
Comment by Iseneschalon Sep 23, 2021 11:00am

RE:FWBI ...... I will start a small position .....

LMFAO....That was fast ....now in the red......going to pick my spot now  Cheers !
Post by Iseneschalon Sep 23, 2021 10:56am

FWBI ...... I will start a small position .....

if this goes green to red today  Currently green.... up 2 cents trading at ~ $3.54  Cheers !
Post by Iseneschalon Sep 23, 2021 10:21am

FWBI ....... It's a done deal......

AZRX is now FWBI On watch and will be a shareholder before you can say $FiveForty....  Cheers !
Post by Iseneschalon Sep 21, 2021 1:03pm

AZRX ...... RS Merger & NC.....

The full 9 yards..... On watch   AzurRx BioPharma to Change Corporate Name to First Wave BioPharma Today   2021-09-21 09:48 PT - News Release   BOCA RATON, Fla., Sept. 21 ...more  
Post by askretkaon Mar 25, 2021 8:32pm

Up 9.76% today

Better than most. Always nice to see buying of a stock you own on a down day.
Post by askretkaon Mar 23, 2021 2:48pm

Welcome mevani

$3.50 target reiterated today. By analyst. Glad I'm not just here talking to myself anymore. Let's make some more money! Cheers!
Comment by mevanion Mar 18, 2021 1:12am

RE:Moving again up nice todat

News any day now.  I am loaded and locked.  Good luck to you.
Post by askretkaon Mar 15, 2021 10:16am

Moving again up nice todat

low target on this is 3$ US I'm back in 2nd time around with free shares. Cheers!
Post by askretkaon Feb 16, 2021 1:05pm

Bought back in today new Target $3.50

Analyst raises target from 2$ to $3.50 Bought back in with smaller position for longer term.
Post by askretkaon Jan 25, 2021 7:22pm

SOLD TODAY 150% profit in a few days

Long term I think it has lots of potential but over 150% profit since the 13 January too hard to resist. Cheers!
Post by askretkaon Jan 22, 2021 9:34pm

Up 48% today. Up 35.5% Yesterday

Not sure what tomorrow will bring But looks like this stock is in play.
Post by askretkaon Jan 22, 2021 12:53pm

Up 69% on the day at the moment

Bought in a 0.86 recently. Hope a couple other people got on board.
Post by askretkaon Jan 22, 2021 9:09am

2$ Buy target maintained today

By HC Wainwright analyst Yi Chen ---- That's the low 1yr target on this stock AVERAGE 4$ HIGH $7 CHEERS!
Post by askretkaon Jan 21, 2021 8:21pm

UP 34.5 % today

Long term Biotech play. Current New average Analyst Target 4.00 3 products now scheduled for trials. 3 shots on goal for 2021. Billion dollar markets.
Post by askretkaon Jan 21, 2021 3:20pm

Up 45% at.moment

Wonder where we will endvthe day?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities